US Bancorp’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.2K | Buy |
4,332
+257
| +6% | +$2.21K | ﹤0.01% | 2853 |
|
|
2025
Q4 | $42.3K | Buy |
4,075
+3,701
| +990% | +$38.8K | ﹤0.01% | 2770 |
|
|
2025
Q3 | $3.31K | Sell |
374
-35,430
| -99% | -$253K | ﹤0.01% | 3651 |
|
|
2025
Q2 | $207K | Sell |
35,804
-3,823
| -10% | -$23.4K | ﹤0.01% | 1998 |
|
|
2025
Q1 | $262K | Buy |
39,627
+17,523
| +79% | +$137K | ﹤0.01% | 1857 |
|
|
2024
Q4 | $193K | Buy |
22,104
+14,335
| +185% | +$206K | ﹤0.01% | 2045 |
|
|
2024
Q3 | $152K | Sell |
7,769
-1,410
| -15% | -$28.6K | ﹤0.01% | 2181 |
|
|
2024
Q2 | $189K | Buy |
9,179
+543
| +6% | +$11.2K | ﹤0.01% | 2034 |
|
|
2024
Q1 | $184K | Buy |
8,636
+6,539
| +312% | +$127K | ﹤0.01% | 2052 |
|
|
2023
Q4 | $30.2K | Buy |
2,097
+651
| +45% | +$6.4K | ﹤0.01% | 2889 |
|
|
2023
Q3 | $13.2K | Buy |
1,446
+354
| +32% | +$3.59K | ﹤0.01% | 3064 |
|
|
2023
Q2 | $11.6K | Buy |
1,092
+207
| +23% | +$2.45K | ﹤0.01% | 3210 |
|
|
2023
Q1 | $10.8K | Sell |
885
-736
| -45% | -$9.18K | ﹤0.01% | 3252 |
|
|
2022
Q4 | $20.1K | Buy |
1,621
+177
| +12% | +$2.57K | ﹤0.01% | 2986 |
|
|
2022
Q3 | $20K | Buy |
1,444
+1,310
| +978% | +$20.2K | ﹤0.01% | 3015 |
|
|
2022
Q2 | $2K | Sell |
134
-480
| -78% | -$6.91K | ﹤0.01% | 3845 |
|
|
2022
Q1 | $10K | Buy |
+614
| New | +$8.87K | ﹤0.01% | 3371 |
|
|
2021
Q4 | – | Sell |
-847
| Closed | -$16K | – | 4174 |
|
|
2021
Q3 | $16K | Buy |
847
+547
| +182% | +$10.3K | ﹤0.01% | 3234 |
|
|
2021
Q2 | $7K | Buy |
300
+284
| +1,775% | +$7.05K | ﹤0.01% | 3522 |
|
|
2021
Q1 | $0 | Sell |
16
-61
| -79% | -$1.93K | ﹤0.01% | 3925 |
|
|
2020
Q4 | $3K | Buy |
+77
| New | +$2.71K | ﹤0.01% | 3505 |
|
Other funds holding KURA
SCM
BI
VCM
AC
PM
DTC
